Clinical Trial Update: Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the Hand [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gevokizumab for erosive osteoarthritis of the hand has completed, reporting safety and biologic activity results. The trial assessed sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Hand
• Osteoarthritis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED